Nathaniel Hendrix

Harvard University

H指数:15

被引数:663

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incorporating equity and financial protection criteria into essential benefits package design: a case study of infectious diseases interventions in Ethiopia.

将公平性和财务保护标准纳入基本保障包设计：以埃塞俄比亚传染病干预措施为例的研究。

Value in Health

IF6

2026-02-160

PRE

Documentation of Compounded GLP-1 Receptor Agonists in a Large Primary Care Dataset

大型初级保健数据集中复方GLP-1受体激动剂的记录

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

IF2.4

2025-09-300

PRE

Natural language processing improves reliable identification of COVID-19 compared to diagnostic codes alone

自然语言处理相比仅使用诊断编码，提高了COVID-19的可靠识别。

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2025-08-010

PRE

An Intersectional Analysis of Social Deprivation and Patient Characteristics on Nirmatrelvir-Ritonavir for Treatment of COVID-19 in U.S. Primary Care Practices, 2021 to 2023

交叉分析社会剥夺与患者特征对Nirmatrelvir-Ritonavir治疗COVID-19的影响：美国初级保健实践，2021年至2023年

Journal of Primary Care & Community Health

IF2.5

2025-07-160

Heterogeneity of diagnosis and documentation of post-COVID conditions in primary care: A machine learning analysis

初级保健中后COVID状态诊断和记录的异质性：一项机器学习分析

PLOS ONE

IF2.6

2025-05-160

Variation in Family Physicians' Experiences Across Different Electronic Health Record Platforms: a Descriptive Study

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2023-03-234

OAAI

Equitable Prioritization of Health Interventions by Incorporating Financial Risk Protection Weights Into Economic Evaluations

VALUE IN HEALTH

IF6

2023-03-013

OAAI

Radiologist Preferences for Artificial Intelligence-Based Decision Support During Screening Mammography Interpretation

在筛查乳房x线照相术解释期间，放射科医生对基于人工智能的决策支持的偏好

JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY

IF5.1

2022-10-018

OAAI

Economic evaluations of health system strengthening activities in low-income and middle-income country settings: a methodological systematic review

BMJ GLOBAL HEALTH

IF6.1

2022-03-112

OAAI

Assessing the Economic Value of Clinical Artificial Intelligence: Challenges and Opportunities

VALUE IN HEALTH

IF6

2022-03-0126

OAAI

Estimating the long-term risk of recurrence in patients receiving HER2-targeted agents in HER2+early-stage breast cancer (ESBC)

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Population effectiveness model of the consequences of recurrence after trastuzumab emtansine (T-DM1) treatment among US patients with high-risk HER2+early-stage breast cancer (ESBC)

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Population effectiveness model of the consequences of recurrence after trastuzumab emtansine (T-DM1) treatment among US patients with high-risk HER2+early-stage breast cancer (ESBC)

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

OAAI

Economic Evaluation of Urine-Based or Magnetic Resonance Imaging Reflex Tests in Men With Intermediate Prostate-Specific Antigen Levels in the United States

VALUE IN HEALTH

IF6

2021-08-0116

OAAI

Clarifying the Trade-Offs of Risk-Stratified Screening for Prostate Cancer: A Cost-Effectiveness Study

明确前列腺癌风险分层筛查的权衡: 一项成本效益研究

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2021-05-229

OAAI

Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses

MEDICAL DECISION MAKING

IF2.3

2021-01-154

OAAI

Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries

CLINICAL INFECTIOUS DISEASES

IF7.3

2019-03-075

OAAI

WHAT US HEALTHCARE PROVIDERS VALUE IN GENOMIC PRECISION MEDICINE: A DISCRETE CHOICE EXPERIMENT

VALUE IN HEALTH

IF6

2018-05-010

OAAI

Favorable and publicly funded studies are more likely to be published: a systematic review and meta-analysis

JOURNAL OF CLINICAL EPIDEMIOLOGY

IF5.2

2017-12-0116

PREAI

Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2017-06-058

OAAI

Nathaniel Hendrix

个人简介

教育背景

工作经历

荣誉奖项

研究方向